Abstract
Post-resuscitative induced hypothermia lowers mortality, reduces neurologic impairment after cardiac arrest, and is recommended by 2005 CPR guidelines of American Heart Association. This article reviews the mechanisms of hypothermic neuroprotection, the clinical trials that support its use after cardiac arrest, as well as the impact of hypothermia on patient management and prognosis. In caring for patients suffering ischemic brain injury after cardiac arrest, the role of the physician is no longer limited to conventional therapy but also extends to active involvement in clinical management which includes the use of therapeutic hypothermia. Therapeutic hypothermia is a feasible treatment and can be used safely and effectively at emergency department and ICU setting.
References
1. Hwang SO, Kim SH, et al. 2006 KACPR guideline for CPR. 2006. 1st ed. Seoul: KACPR;1–4.
2. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001. 104:2158–2163.
3. Cummins RO, Ornato JP, Thies WH, Pepe PE. Improving survival from sudden cardiac arrest: the "chain of survival" concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association. Circulation. 1991. 83:1832–1847.
4. Maramattom BV, Wijdicks EF. Postresuscitation encephalopathy. Current views, management, and prognostication. Neurologist. 2005. 11:234–243.
5. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out of hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002. 346:557–563.
6. The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002. 346:549–556.
7. Holzer M, Bernard SA, Hachimi Idrissi S, Roine RO, Sterz F, Muller M. Collaborative group on induced hypothermia for neuroprotection after cardiac arrest: Hypothermia for neuroprotection after cardiac arrest: systemic review and individual patient data meta analysis. Crit Care Med. 2005. 33:414–418.
9. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 1995. 146:3–15.
10. Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl). 1990. 181:195–213.
11. White BC, Sullivan JM, DeGracia DJ, Neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause GS. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci. 2000. 179:1–33.
12. Otis AB, Jude J. Effect of body temperature on pulmonary gas exchange. Am J Physiol. 1957. 188:355–359.
13. Wong KC. Physiology and pharmacology of hypothermia. West J Med. 1983. 138:227–232.
14. McCullough JN, Zhang N, Reich DL, Juvonen TS, Klein JJ, Spielvogel D, Ergin MA, Griepp RB. Cerebral metabolic suppression during hypothermic circulatory arrest in humans. Ann Thorac Surg. 1999. 67:1895–1899.
15. Harada K, Maekawa T, Tsuruta R, Kaneko T, Sadamitsu D, Yamashima T, Yoshida Ki K. Hypothermia inhibits translocation of CaM kinase II and PKC-alpha, beta, gamma isoforms and fodrin proteolysis in rat brain synaptosome during ischemiareperfusion. J Neurosci Res. 2002. 67:664–669.
16. Globus MYT, Busto R, Lin B, Schnippering H, Ginsberg MD. Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation. J Neurochem. 1995. 65:1250–1256.
17. Zheng Z, Yenari MA. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol Res. 2004. 26:884–892.
18. Felberg RA, Krieger DW, Chuang R, Persse DE, Burgin WS, Hickenbottom SL, Morgenstern LB, Rosales O, Grotta JC. Hypothermia after cardiac arrest: feasibility and safety of an external cooling protocol. Circulation. 2001. 104:1799–1804.
19. Diringer MN. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med. 2004. 32:559–564.
20. Virkkunen I, Yli-Hankala A, Silfvast T. Induction of therapeutic hypothermia after cardiac arrest in prehospital patients using ice-cold Ringer's solution: a pilot study. Resuscitation. 2004. 62:299–302.
21. Mayer SA, Kowalski RG, Presciutti M, Ostapkovich ND, McGann E, Fitzsimmons BF, Yavagal DR, Du YE, Naidech AM, Janjua NA, Claassen J, Kreiter KT, Parra A, Commichau C. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med. 2004. 32:2508–2515.
22. Valeri CR, MacGregor H, Cassidy G, Tinney R, Pompei F. Effects of temperature on bleeding time and clotting time in normal male and female volunteers. Crit Care Med. 1995. 23:698–704.
23. Kim JJ, Shin JH, Lim YS, Kim CK, Kim JK, Hyun SY, Yang HJ, Lee G, Choi YC. Relative adrenal insufficiency in postresuscitation patients. J Korean Soc Emerg Med. 2008. 19:498–505.
24. Levy DE, Bates D, Caronna JJ, Cartlidge NE, Knill-Jones RP, Lapinski RH, Singer BH, Shaw DA, Plum F. Prognosis in nontraumatic coma. Ann Intern Med. 1981. 94:293–301.
25. Booth CM, Boone RH, Tomlinson G, Detsky AS. Is this patient dead, vegetative, or severely neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest. JAMA. 2004. 291:870–879.
26. Zandbergen EG, de Haan RJ, Hijdra A. Systematic review of prediction of poor outcome in anoxic-ischaemic coma with biochemical markers of brain damage. Intensive Care Med. 2001. 27:1661–1667.
27. Tiainen M, Roine RO, Pettila V, Takkunen O. Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke. 2003. 34:2881–2886.
28. Hachimi-Idrissi S, Zizi M, Nguyen DN, Schiettecate J, Ebinger G, Michotte Y, Huyghens L. The evolution of serum astroglial S-100 [beta] protein in patients with cardiac arrest treated with mild hypothermia. Resuscitation. 2005. 64:187–192.